Literature DB >> 8240102

Heteroplasmy in Leber's hereditary optic neuropathy.

K H Smith1, D R Johns, K L Heher, N R Miller.   

Abstract

OBJECTIVES: To determine the incidence and clinical significance of peripheral blood heteroplasmy and the presence of normal and mutant mitochondrial DNA in Leber's hereditary optic neuropathy through evaluation of a large series of families with the 11778 mutation and to evaluate the pattern of transmission of heteroplasmy.
DESIGN: We studied heteroplasmy in 75 visually symptomatic patients with the 11778 mutation and in 101 asymptomatic family members. We compared the incidence of heteroplasmy in these two groups, collected clinical information for each symptomatic patient, and calculated the incidence of heteroplasmy within each generation of the pedigrees.
RESULTS: We detected heteroplasmy in 24 (14%) of the 176 persons tested. Kaplan-Meier life-table analysis suggests that heteroplasmic persons are more likely to remain asymptomatic than those who are homoplasmic mutant (males, P = .17; females, P = .14). However, heteroplasmic persons who become symptomatic do not seem to differ clinically from symptomatic patients who are homoplasmic mutant. Pedigree analysis reveals a strong tendency for progression from heteroplasmy toward homoplasmy in subsequent generations (P = .001).
CONCLUSION: Heteroplasmy for the 11778 mutation seems to play a role in the clinical expression of Leber's hereditary optic neuropathy and tends to progress toward homoplasmy in successive generations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240102     DOI: 10.1001/archopht.1993.01090110052022

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  39 in total

1.  The epidemiology of Leber hereditary optic neuropathy in the North East of England.

Authors:  P Yu-Wai-Man; P G Griffiths; D T Brown; N Howell; D M Turnbull; P F Chinnery
Journal:  Am J Hum Genet       Date:  2002-01-07       Impact factor: 11.025

2.  Leber's hereditary optic neuropathy with 14484 mutation in Central Java, Indonesia.

Authors:  Tomoki Nishioka; Mamoru Tasaki; Augustinus Soemantri; Marbaniati Dyat; J C Susanto; Moedrik Tamam; Bambang Sudarmanto; Takafumi Ishida
Journal:  J Hum Genet       Date:  2003-06-24       Impact factor: 3.172

3.  [Leber's hereditary optic neuropathy].

Authors:  B Leo-Kottler; B Wissinger
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

4.  De novo COX2 mutation in a LHON family of Caucasian origin: implication for the role of mtDNA polymorphism in human pathology.

Authors:  Sergey I Zhadanov; Vasiliy V Atamanov; Nikolay I Zhadanov; Theodore G Schurr
Journal:  J Hum Genet       Date:  2006-01-18       Impact factor: 3.172

5.  [Hereditary optic atrophies].

Authors:  C M Poloschek; W A Lagrèze
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

Review 6.  Advances in genetics.

Authors:  M M Lees; R M Winter
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

7.  Leber's hereditary optic neuropathy (LHON) in an Apulian cohort of subjects.

Authors:  Angelica Bianco; Luigi Bisceglia; Paolo Trerotoli; Luciana Russo; Leonardo D'Agruma; Silvana Guerriero; Vittoria Petruzzella
Journal:  Acta Myol       Date:  2017-09-01

8.  Transmission of heteroplasmic G11778A in extensive pedigrees of Thai Leber hereditary optic neuropathy.

Authors:  Nopasak Phasukkijwatana; Wanicha L Chuenkongkaew; Rungnapa Suphavilai; Komon Luangtrakool; Bussaraporn Kunhapan; Patcharee Lertrit
Journal:  J Hum Genet       Date:  2006-10-28       Impact factor: 3.172

9.  Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation.

Authors:  A E Harding; M G Sweeney; G G Govan; P Riordan-Eva
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

10.  Identification of novel mitochondrial mutations in Leber's hereditary optic neuropathy.

Authors:  Manoj Kumar; Mukesh Tanwar; Rohit Saxena; Pradeep Sharma; Rima Dada
Journal:  Mol Vis       Date:  2010-04-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.